Clinical trial

Pharmacology of Adjuvant Hormonotherapy in Breast Cancer

NCT01127295

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-06-17

PhasePHASE4

Study timeline

Study start (actual)2010-06-17Date precision: day

Registry last updated2026-04-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hormono-depending Adjuvant Breast Cancerunresolved

Interventions

Tamoxifen, Letrozole, Anastrozole or ExemestaneDRUG

Sponsors & collaborators

Institut Claudius Regaudlead sponsor

Mapped research locations

ToulouseFrance5 BordeauxFrance4 MontpellierFrance1 NîmesFrance1 LimogesFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01127295 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.